NFKB1 and polyarteritis nodosa: Moreover, we provided evidence for the inhibitory potential of PAN by showing that this drug significantly reduced STAT5 activation by IL-15 in NK and CD4+ T cells as well as PRO-induced activation of NF-κB in CD4+ T cells.